Stay updated on Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.

Latest updates to the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe banner about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology is no longer displayed.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces an NIH website transition and says “Super Intelligence” is replacing “Artificial Intelligence” in agency content.SummaryDifference1%

- Check28 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record area now shows a 403 Forbidden message with a Home link. The site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.7%

- Check42 days agoChange DetectedThe 403 Forbidden message and its Home link disappeared, leaving the study-record area blank beneath the breadcrumb.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Sunitinib in Variant Histology RCC Clinical Trial page.